Regeneron Pharmaceuticals, Inc.
ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

Last updated:

Abstract:

The present invention includes an antibody or antigen-binding fragment thereof that binds specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., influenza virus infections).

Status:
Application
Type:

Utility

Filling date:

20 Jan 2021

Issue date:

29 Jul 2021